86-34-0
86-34-0 结构式
基本信息
米浪丁
苯琥胺
苯琥胺 USP标准品
1-甲基-3-苯基-2,5-吡咯烷二酮
1-甲基-3-苯基吡咯烷-2,5-二酮
Lifen
Epimid
Lifene
PM 334
Epimal
Mirotin
Milontin
Milonton
Mirontin
物理化学性质
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2025/05/22 | HY-B1730 | 密朗丁 Phensuximide | 86-34-0 | 5 mg | 610元 |
| 2025/05/22 | HY-B1730 | 密朗丁 Phensuximide | 86-34-0 | 10mM * 1mLin DMSO | 671元 |
| 2025/05/22 | HY-B1730 | 密朗丁 Phensuximide | 86-34-0 | 10mg | 980元 |
常见问题列表
IC50: cyclic AMP and cyclic GMP accumulation
Phensuximide produce depolarization-induced accumulation of cyclic GMP or cyclic AMP levels with ID 50 values of 8.00 mM or 6.20 mM in incubated slices of mouse cerebral cortex.Phensuximide (0.5-2.0 mM) has the ability to competitively inhibit mephenytoin 4-hydroxylase activity in human liver microsomes, the K i and K m values are 559 μM and 235 μM, respectively.
Phensuximide (intraperitoneal injection; 1.25 mmol/kg; single dose) induces mild changes in renal function, including: trace hematuria, increased proteinuria and decreased paminohippurate uptake in Sprague-Dawley rats.Phensuximide (intraperitoneal injection; 0.3 or 0.6 mmol/kg; 5-7 days) results in transient hematuria and proteinuria, but no change in the other renal function parameters studied. It is concluded that phensuximide produces mild, transient renal effects in Fischer 344 rats, and that the Fischer 344 rat is a suitable model for studying phensuximide-induced toxicity to the urinary tract.
| Animal Model: | Fischer 344 rats |
| Dosage: | 0.3 or 0.6 mmol/kg |
| Administration: | Intraperitoneal injection; 5-7 days |
| Result: | Induced urotoxicity following daily administration for 5-7 days in Fischer 344 rats. |